ESTIMATED
04/16/2024
04/16/2024
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$9.90 | -$9.90 | -$9.90 |
Q2 2024 | 0 | -$9.72 | -$9.72 | -$9.72 |
Q3 2024 | 0 | -$6.66 | -$6.66 | -$6.66 |
Q4 2024 | 0 | -$6.30 | -$6.30 | -$6.30 |
Q1 2025 | 0 | -$3.60 | -$3.60 | -$3.60 |
Q2 2025 | 0 | -$1.98 | -$1.98 | -$1.98 |
Q3 2025 | 0 | -$1.08 | -$1.08 | -$1.08 |
Q4 2025 | 0 | $0.36 | $0.36 | $0.36 |
Windtree Therapeutics, Inc. last posted its earnings results on Tuesday, April 16th, 2024. The company reported $-13.31 earnings per share for the quarter, missing analysts' consensus estimates of $-0.94 by $12.37. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Windtree Therapeutics, Inc. has generated $-5 earnings per share over the last year ($-5.24 diluted earnings per share) and currently has a price-to-earnings ratio of -0.25. Windtree Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/29/2024 | Q1 2024 | $21.98 | $0 | $0 | 12/30/2023 | Q4 2023 | -$1.33 | $0 | $0 | 11/09/2023 | Q3 2023 | -$0.63 | -$0.86 | -0.23 | $0 | $0 | 08/07/2023 | Q2 2023 | -$0.68 | -$1.64 | -0.96 | $0 | 05/15/2023 | Q1 2023 | -$0.56 | -$95.73 | -95.17 | $0 | 03/31/2023 | Q4 2022 | -$15.38 | $100,000 | $0 | 11/14/2022 | Q3 2022 | -$269.78 | -$5.56 | 264.22 | $50,000 | $0 | 08/11/2022 | Q2 2022 | -$98.92 | -$29.33 | 69.59 | $200,000 | $0 | 05/05/2022 | Q1 2022 | -$278.78 | -$14.00 | 264.78 | $0 | 03/31/2022 | Q4 2021 | -$296.76 | -$0.49 | 296.27 | $0 | 11/10/2021 | Q3 2021 | -$269.78 | -$15.38 | 254.4 | $0 | 08/05/2021 | Q2 2021 | -$467.63 | -$70.95 | 396.68 | $0 | 05/13/2021 | Q1 2021 | -$15.00 | -$25.32 | -10.32 | $0 | 03/29/2021 | Q4 2020 | -$377.70 | -$0.42 | 377.28 | $0 | 11/16/2020 | Q3 2020 | -$440.65 | -$27.20 | 413.45 | $0 | 08/14/2020 | Q2 2020 | -$31.67 | $0 | 05/13/2020 | Q1 2020 | -$23.85 | $0 | 04/02/2020 | Q4 2019 | -$31.98 | $0 | 11/14/2019 | Q3 2019 | -$33.21 | $0 | 08/14/2019 | Q2 2019 | -$30.00 | $158,000 |
---|
A. Windtree Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates.
A. The conference call for Windtree Therapeutics, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Windtree Therapeutics, Inc.'s latest earnings report can be read online.
A. Windtree Therapeutics, Inc. (NASDAQ:WINT) has a recorded net income of $0. Windtree Therapeutics, Inc. has generated $-5.24 earnings per share over the last four quarters.
A. Windtree Therapeutics, Inc. (NASDAQ:WINT) has a price-to-earnings ratio of -0.25 and price/earnings-to-growth ratio is -0.